However, sustained mal-regulated activation of mTOR during heart failure promotes ventricular hypertrophy as well as detrimental cardiac remodeling; however, partial inhibition of mTOR prevents ventricular fibrosis in hypertrophic cardiomyopathy models [75, 76]. Here, MTOR is linked to cardiac hypertrophy.